Palomar StarLux Light-Based System Featured on ABC's 'The View'

Palomar StarLux Light-Based System Featured on ABC's 'The View'

BURLINGTON, Mass., June 1 /PRNewswire-FirstCall/ -- Palomar Medical Technologies Inc (NASDAQ:PMTI), a leading researcher and developer of light- based systems for cosmetic treatments, today announced some of its products were featured on ABC Daytime Television's Talk Show "The View" in yesterday's episode titled "The Cutting Edge of Beauty." Arielle Kauvar MD, a Director at New York Laser and Skin Care Center, joined co-hosts Barbara Walters, Meredith Vieira, Star Jones Reynolds, Joy Behar, and Elisabeth Hasselbeck as they examined the latest cosmetic treatments and beauty secrets of the stars. Featuring new technology capable of addressing multiple cosmetic applications, Dr. Kauvar highlighted one of Palomar's light-based aesthetic platforms, the StarLux, and its corresponding interchangeable laser handpiece, the Lux1064, for the treatment and removal of varicose veins. Live digital footage was provided to audience members to observe the actual closings of vessels instantaneously.

Commenting on Palomar's inclusion on "The View," Palomar Chief Executive Officer, Joseph P. Caruso said, "Following our ranking as number four in BusinessWeek's 'Top 100 Hot Growth Companies,' exposure on 'The View' not only reaffirms our position in the marketplace, but also highlights the recent surge in consumer interest for noninvasive cosmetic treatments. This type of exposure to the masses will fuel demand for these types of new cosmetic light based procedures that are still virtually unknown to the general population.

"This episode featured the removal of veins. Palomar's proprietary technology provides dramatic improvement of veins in just one painless treatment. Our technology is also capable of addressing multiple cosmetic applications through multi-use, versatile and cost effective platforms including permanent hair removal, photofacials through the removal of vascular and pigmented lesions, and acne. The increasing exposure on Palomar validates our leadership in technology and in the aesthetic market with results that can only be achieved using light based treatments. We are pleased that our products are being recognized by the medical community as safe, effective systems capable of high end results and satisfied customers."

"The View," is a recipient of the 2003 Daytime Emmy Award for "Outstanding Talk Show" and is produced by ABC News correspondent Barbara Walters. Deemed ABC Daytime's 'morning chat fest,' "The View" features a team of five dynamic women of different ages, experiences and backgrounds discussing the most exciting events of the day. Many of the topics discussed consist of recent events in the news, top trends and experts in the field, celebrity interviews and general entertainment. The program celebrated its 1500th show on January 23, 2004 and is currently in its seventh season.

About Palomar Medical Technologies Inc: Palomar is a leading researcher and developer of light-based systems for cosmetic treatments. Palomar pioneered the optical hair removal field, when, in 1997, it introduced the first high-powered laser hair removal system. Since then, many of the major advances in light-based hair removal have been based on Palomar technology. There are now millions of light-based cosmetic procedures performed around the world every year in physician offices, clinics, spas and salons. Palomar is testing many new and exciting indications to further advance the hair removal market and other cosmetic applications. Palomar is uniquely focused on developing proprietary light-based technology for introduction to the mass markets. Palomar has an agreement with The Gillette Company (NYSE:G) to develop and potentially commercialize a patented home-use, light-based hair removal device for women, and an agreement with Johnson & Johnson Consumer Companies to develop and potentially commercialize home-use, light-based devices for reducing or reshaping body fat including cellulite, reducing the appearance of skin aging, and reducing or preventing acne. For more information on Palomar and its products, visit Palomar's website at http://www.palomarmedical.com/. To continue receiving the most up-to-date information and latest news on Palomar as it happens, sign up to receive automatic e-mail alerts by going to the E-mail Alerts page in the Investor Relations' section of the website.

With the exception of the historical information contained in this release, the matters described herein contain forward-looking statements, including but not limited to statements relating to new markets, development and introduction of new products, and financial projections that involve risk and uncertainties that may individually or mutually impact the matters herein, and cause actual results, events and performance to differ materially from such forward-looking statements. These risk factors include, but are not limited to, results of future operations, technological difficulties in developing or introducing new products, the results of future research, lack of product demand and market acceptance for current and future products, the effect of economic conditions, challenges in managing joint ventures and research with third parties and government contracts, the impact of competitive products and pricing, governmental regulations with respect to medical devices, including whether FDA clearance will be obtained for future products, the results of litigation, difficulties in collecting royalties, potential infringement of third-party intellectual property rights, and/or other factors, which are detailed from time to time in the Company's SEC reports, including the report on Form 10-K for the year ended December 31, 2004 and the Company's quarterly reports on Form 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Contacts: Investor Relations Palomar Medical Technologies Inc 781-993-2411 ir@palomarmedical.com

Source: Palomar Medical Technologies Inc

CONTACT: Investor Relations of Palomar Medical Technologies Inc, +1-781- 993-2411, ir@palomarmedical.com

Web site: http://www.palmed.com/

Company News On-Call: http://www.prnewswire.com/comp/107555.html

------- Profile: Ent